We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

153 hedge funds and large institutions have $332M invested in Filana Therapeutics in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 36

27% more call options, than puts

Call options by funds: $133M | Put options by funds: $105M

0.73% more ownership

Funds ownership: 26.23% → 26.96% (+0.73%)

13% less funds holding

Funds holding: 175 → 153 (-22)

24% less capital invested

Capital invested by funds: $439M → $332M (-$107M)

43% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 42

Holders
153
Holders Change
-22
Holders Change %
-12.57%
% of All Funds
2.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
50
Reduced
36
Closed
42
Calls
$133M
Puts
$105M
Net Calls
+$28.1M
Net Calls Change
-$75.1M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$5.9M
2
Group One Trading
Group One Trading
Illinois
+$3.76M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.13M
4
Goldman Sachs
Goldman Sachs
New York
+$2.96M
5
N
Nuveen
North Carolina
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$6.58M
2
Bank of America
Bank of America
North Carolina
-$5.93M
3
GC
GMT Capital
Georgia
-$4.81M
4
TI
Think Investments
California
-$4.67M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$4.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFD
126
Creative Financial Designs
Indiana
$4.14K – – –
IA
127
IFP Advisors
Florida
$4K – – –
S
128
SignatureFD
Georgia
$3.57K -$863 -24 -17%
RMC
129
Resources Management Corp
Connecticut
$3K – – –
SFG
130
Steward Financial Group
Texas
$3K +$4.31K +120 New
LWCFA
131
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$2.81K – – –
TWA
132
TCI Wealth Advisors
Arizona
$2.54K +$3.09K +86 New
AWM
133
Accurate Wealth Management
Florida
$2.34K +$2.7K +75 New
SPIA
134
Steward Partners Investment Advisory
New York
$2.22K – – –
FCMT
135
Founders Capital Management (Texas)
Texas
$2K – – –
HPC
136
HM Payson & Co
Maine
$1.48K -$1.65K -46 -48%
BWM
137
BerganKDV Wealth Management
Minnesota
$1.48K – – –
SSB
138
Sandy Spring Bank
Maryland
$1.48K – – –
IGWM
139
ICA Group Wealth Management
Colorado
$1.48K +$1.8K +50 New
LFG
140
Larson Financial Group
Missouri
$1.15K – – –
CWA
141
Carolina Wealth Advisors
South Carolina
$1K – – –
SWM
142
Spire Wealth Management
Virginia
$1K – – –
BAM
143
Belpointe Asset Management
Nevada
$739 +$899 +25 New
HWMA
144
Heritage Wealth Management (Arizona)
Arizona
$591 +$359 +10 +100%
BIA
145
Bell Investment Advisors
California
$414 +$503 +14 New
NC
146
NewSquare Capital
Pennsylvania
$354 +$431 +12 New
PA
147
Parallel Advisors
California
$295 – – –
EWA
148
EverSource Wealth Advisors
Alabama
$148 – – –
Northwestern Mutual Wealth Management
149
Northwestern Mutual Wealth Management
Wisconsin
$60 +$72 +2 New
NA
150
NewEdge Advisors
Louisiana
$13 +$16.2K +450 New
4 5
6
7 8

FLNA Hedge Fund Activity: Q4 2022 in Review

153 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2022, worth a combined $332M — down 24% from $439M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of FLNA and 24 opened new positions — a net loss of 18 holders — while 36 trimmed existing stakes and 50 added.

The largest buyer was Invesco, adding an estimated $5.9M. The largest seller was Marshall Wace, exiting entirely with an estimated $6.58M sold.

  • 153 institutional investors held Filana Therapeutics (FLNA) as of Q4 2022, down from 175 in Q3 2022.
  • Funds reported $332M of Filana Therapeutics stock for Q4 2022, down 24% quarter-over-quarter.
  • 24 funds opened new Filana Therapeutics positions in Q4 2022 and 42 closed out, a net change of -18 holders.
  • The largest Filana Therapeutics buyer in Q4 2022 was Invesco, an estimated $5.9M added.
  • The largest Filana Therapeutics seller in Q4 2022 was Marshall Wace, an estimated $6.58M sold.

Based on aggregated 13F filings for Q4 2022.